2017
DOI: 10.1136/bmjqs-2016-005879
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the roots of unintended safety threats associated with the introduction of hospital ePrescribing systems and candidate avoidance and/or mitigation strategies: a qualitative study

Abstract: ObjectiveHospital electronic prescribing (ePrescribing) systems offer a wide range of patient safety benefits. Like other hospital health information technology interventions, however, they may also introduce new areas of risk. Despite recent advances in identifying these risks, the development and use of ePrescribing systems is still leading to numerous unintended consequences, which may undermine improvement and threaten patient safety. These negative consequences need to be analysed in the design, implement… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 54 publications
1
32
0
Order By: Relevance
“…We often observed creation of workarounds 25 , loss of user engagement 26 , and unintended safety threats 27 associated with a range of reasons including lack of Anglicization.…”
Section: Resultsmentioning
confidence: 99%
“…We often observed creation of workarounds 25 , loss of user engagement 26 , and unintended safety threats 27 associated with a range of reasons including lack of Anglicization.…”
Section: Resultsmentioning
confidence: 99%
“…Jean Bousquet, MD (1-3), Ignacio J Ansotegui, MD (4), Josep M Anto, PhD (5)(6)(7)(8), Sylvie Arnavielhe, PhD (9), Claus Bachert, MD (10), Xavier Basagaña, PhD (5,7,8), Annabelle Bédard, PhD (5,7,8), Anna Bedbrook, BSc (2), Matteo Bonini, MD (11), Sinthia Bosnic-Anticevich, PhD (12), Fulvio Braido, MD (13), Vicky Cardona, MD (14), Wienczyslawa Czarlewski, MD (15), Alvaro A Cruz, MD (16), Pascal Demoly, MD (17)(18), Govert De Vries, MSc (19), Stephanie Dramburg, MD (47), Eve Mathieu-Dupas, PhD (9), Marina Erhola, PhD (20), Wytske J Fokkens, MD (21), Joao A Fonseca, MD (22), Tari Haahtela, MD (23), Peter W Hellings, MD (24), Maddalena Illario, MD (25), Juan Carlos Ivancevich, MD (26), Vesa Jormanainen, MD (20), Ludger Klimek, MD (27), Piotr Kuna, MD (28), Violeta Kvedariene, MD (29), Daniel Laune, PhD (9), Désirée Larenas-Linnemann, MD (30), Olga Lourenço, PhD (31), Gabrielle L Onorato, MSc (2), Paolo M Matricardi, MD (32), Erik Melén, MD (33), Joaquim Mullol, MD (34), Nikos G Papa...…”
Section: Mobile Technology In Allergic Rhinitis: Evolution In Managemmentioning
confidence: 99%
“…The potential applications and benefits of mHealth are extensive and expanding (4). Implementing mHealth innovations may also have disruptive consequences (5), so it is important to test applicability in each individual situation (6). Appropriately identifying and representing stakeholders' interests and viewpoints in evaluations of mHealth is a critical part of ensuring continued progress and innovation (7).…”
Section: Introductionmentioning
confidence: 99%
“…6 However, recent attempts to implement commercial CPOE/CDS systems have struggled to replicate these benefits and have in some cases yielded unintended consequences where, for example, commercial off-the-shelf (COTS) packaged solutions that were not well-aligned with clinical practices undermined improvements and threatened patient safety. [7][8][9] This disparity in implementation outcomes underlines that the procurement of a system is a necessary, but not sufficient condition for successful adoption. Rather, the outcome of an implementation can be contingent on technical, social, and organizational factors.…”
Section: Background/contextmentioning
confidence: 99%
“…Implementation strategies should be long-term-oriented and incorporate considerations for system optimization to address on-going and emerging concerns over a much longer timeframe than anticipated by existing episodic perspectives. 9 The short-term duration of many investments in this field has come into conflict with the long-term development of use and optimization activities, well beyond initial implementation. We therefore stress the need to allocate on-going financial resources and managerial effort to the post-implementation phase, coupled with the need to extend engagement 21 and sustain implementation support team structures to retain and re-use the internal experience and expertise acquired by team members in the course of the implementation journey.…”
Section: Implications For Policy Practice and Researchmentioning
confidence: 99%